利好！9部门重磅印发

Core Viewpoint - The article discusses the joint issuance of guidelines by the Ministry of Commerce and nine other departments to promote high-quality development in the pharmaceutical retail industry, focusing on enhancing services, innovation, emergency support, industry structure optimization, and regulatory compliance [1][3][4]. Group 1: Enhancing Pharmaceutical Services - The guidelines aim to improve pharmaceutical services by supporting pharmacies to enhance their pharmaceutical service capabilities, optimize purchasing experiences, participate in centralized drug procurement, and establish payment security systems [4][6]. - Pharmacies are encouraged to equip themselves with licensed pharmacists and health consultants, and to provide remote pharmaceutical services [6][7]. - The guidelines promote the flow of prescriptions and enhance the purchasing experience through improved electronic prescription systems and collaboration between medical institutions and pharmacies [6][7]. Group 2: Innovating Health Services - Pharmacies are encouraged to expand health service functions, including medication guidance and health consultations, and to engage in health education activities [9]. - The guidelines support the establishment of remote health consultation centers in pharmacies, particularly in underserved areas, and promote the use of technology for health service upgrades [9][10]. - There is an emphasis on diversifying retail pharmacy formats and enhancing the shopping experience for consumers [9][10]. Group 3: Strengthening Emergency Services - The guidelines call for pharmacies to enhance their service capabilities in emergency supply situations and to participate in drug market monitoring [11][12]. - Pharmacies are encouraged to provide public health education and support during emergencies, such as pandemics or disasters [11][12]. Group 4: Optimizing Industry Structure - The guidelines support mergers and acquisitions among retail pharmacies to improve industry concentration and efficiency [12][13]. - There is a push for integrated development between wholesale and retail sectors to enhance supply chain efficiency and reduce operational costs [13][14]. - The guidelines advocate for a fair pricing system in the pharmaceutical retail market to promote healthy competition [13][14]. Group 5: Regulating Industry Order - The guidelines propose the development of smart regulation to enhance compliance and monitoring within the pharmaceutical retail sector [14]. - There is a focus on promoting fair competition and preventing illegal practices in online and offline pharmaceutical sales [14]. - The guidelines encourage industry self-discipline and the establishment of industry standards to ensure responsible business practices [14].